MoneyWorks4Me

The sales slipped to Rs. 156.52 millions for the March 2023 quarter as against Rs. 167.19 millions during the year-ago period.Net profit for the quarter ended March 2023 increased significantly by 65.71% to Rs. 4.06 millions from Rs. 2.45 millions.Operating profit for the quarter ended March 2023 rose to 20.64 millions as compared to 17.45 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 156.52 167.19 -6.38 661.71 694.30 -4.69 661.71 694.30 -4.69
Other Income 3.11 4.02 -22.64 5.11 5.92 -13.68 5.11 5.92 -13.68
PBIDT 20.64 17.45 18.28 92.87 90.07 3.11 92.87 90.07 3.11
Interest 5.26 5.84 -9.93 23.82 20.66 15.30 23.82 20.66 15.30
PBDT 15.38 11.61 32.47 69.05 69.41 -0.52 69.05 69.41 -0.52
Depreciation 9.96 9.64 3.32 39.17 35.48 10.40 39.17 35.48 10.40
PBT 5.42 1.97 175.13 29.88 33.93 -11.94 29.88 33.93 -11.94
TAX 1.36 -0.48 -383.33 7.47 7.50 -0.40 7.47 7.50 -0.40
Deferred Tax 0.58 0.75 -22.67 1.97 3.05 -35.41 1.97 3.05 -35.41
PAT 4.06 2.45 65.71 22.41 26.43 -15.21 22.41 26.43 -15.21
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 13.19 10.44 26.34 14.03 12.97 8.19 14.03 12.97 8.19
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..